Advertisement
Australia markets close in 5 hours 4 minutes
  • ALL ORDS

    7,891.20
    +30.20 (+0.38%)
     
  • ASX 200

    7,635.10
    +29.50 (+0.39%)
     
  • AUD/USD

    0.6445
    +0.0009 (+0.13%)
     
  • OIL

    82.70
    +0.01 (+0.01%)
     
  • GOLD

    2,384.50
    -3.90 (-0.16%)
     
  • Bitcoin AUD

    95,527.81
    -3,846.46 (-3.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6037
    +0.0011 (+0.18%)
     
  • AUD/NZD

    1.0890
    +0.0017 (+0.16%)
     
  • NZX 50

    11,810.21
    -65.14 (-0.55%)
     
  • NASDAQ

    17,493.62
    -220.04 (-1.24%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • Dow Jones

    37,753.31
    -45.66 (-0.12%)
     
  • DAX

    17,770.02
    +3.79 (+0.02%)
     
  • Hang Seng

    16,251.84
    +2.87 (+0.02%)
     
  • NIKKEI 225

    37,703.75
    -258.05 (-0.68%)
     

Why Abbott Laboratories Shot Higher Today

Why Abbott Laboratories Shot Higher Today

Abbott Laboratories (NYSE: ABT) easily surmounted Hump Day, rising by 3.4% and trouncing the S&P 500 index's gain as it did so. For the quarter, Abbott posted year-over-year sales growth of 23%, as its top line landed at $10.9 billion. Collectively, prognosticators tracking the healthcare company estimated that it would earn a bit more than $9.4 billion on the top line and post an adjusted net profit of $0.93.